Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial.
Michael L FriedlanderLinda MileshkinJanine LombardSophia FrentzasBo GaoMichelle WilsonTarek MeniawySally Baron-HayKaren BriscoeNicole McCarthyChristos FountzilasAndres CervantesRuimin GeJohn WuAlexander SpiraPublished in: British journal of cancer (2023)
ClinicalTrial.gov: NCT02660034.